228
Views
2
CrossRef citations to date
0
Altmetric
ARTICLE

Pregnancy Outcomes in Wilson’s Disease Women: Single-Center Case Series

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 741-748 | Received 16 May 2021, Accepted 22 Jul 2021, Published online: 05 Aug 2021

References

  • Ferenci P, Czlonkowska A, Stremmel W, et al. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–85. doi:10.1016/j.jhep.2011.11.007.
  • Rosencrantz R, Schilsky M. Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis. 2011;31(3):245–59. doi:10.1055/s-0031-1286056.
  • Tarnacka B, Rodo M, Cichy S, Członkowska A. Procreation ability in Wilson’s disease. Acta Neurol Scand. 2000;101(6):395–8. doi:10.1034/j.1600-0404.2000.90140a.x.
  • Klee J. Undiagnosed Wilson’s disease as cause of unexplained miscarriage. Lancet. 1979;314(8139):423. doi:10.1016/S0140-6736(79)90440-9.
  • Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, Gauss A, Stremmel W, Schilsky ML, Ferenci P, et al. Pregnancy in Wilson’s disease: management and outcome. Hepatology. 2018;67(4):1261–9. doi:10.1002/hep.29490.
  • Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089–111. doi:10.1002/hep.22261.
  • Tanaka H, Inomata K, Arima M. Teratogenic effects of triethylene tetramine dihydrochloride on the mouse brain. J Nutr Sci Vitaminol (Tokyo). 1993;39(2):177–88. doi:10.3177/jnsv.39.177.
  • Keen CL, Mark-Savage P, Lönnerdal B, Hurley LS. Teratogenic effects of D-penicillamine in rats: relation to copper deficiency. Drug Nutr Interact. 1983;2(1):17–34.
  • Pinter R, Hogge WA, McPherson E. Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am J Med Genet. 2004; 128A(3):294–298. doi:10.1002/ajmg.a.10871.
  • Mjolnerod OK, Dommerud SA, Rasmussen K, Gjeruldsen ST. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet. 1971;1(7701):673–5. doi:10.1016/S0140-6736(71)92681-X.
  • Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ. Treatment of Wilson’s disease with zinc. XVII: treatment during pregnancy. Hepatology. 2000;31(2):364–70. doi:10.1002/hep.510310216.
  • Cheung K, Seto W, Fung J, Mak L, Lai C, Yuen M. Epidemiology and natural history of Wilson’s disease in the Chinese: a territory-based study in Hong Kong between 2000 and 2016. WJG. 2017;23(43):7716–26. doi:10.3748/wjg.v23.i43.7716.
  • Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease. J Neurol Sci. 2004;217(1):37–40. doi:10.1016/j.jns.2003.08.007.
  • Léonard A, Gerber GB, Léonard F. Mutagenicity, carcinogenicity and teratogenicity of zinc. Mutat Res Genet Toxicol. 1986;168(3):343–353. doi:10.1016/0165-1110(86)90026-6.
  • Anderson LA, Hakojarvi SL, Boudreaux SK. Zinc acetate treatment in Wilson’s disease. Ann Pharmacother. 1998;32(1):78–87. doi:10.1345/aph.17075.
  • Aggarwal A, Bhatt M. Advances in treatment of Wilson disease. Tremor Other Hyperkinetic Mov. 2018;8:525 doi:10.7916/D841881D.
  • Ishiwa S, Sato M, Morisada N, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Kosuga M, Kamei K, et al. Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution. Pediatr Nephrol. 2019;34(8):1457–64. doi:10.1007/s00467-019-04230-w.
  • Nicolaou N, Renkema K, Bongers E, Giles R, Knoers N. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol. 2015;11(12):720–31. doi:10.1038/nrneph.2015.140.
  • Gambling L, Kennedy C, McArdle HJ. Iron and copper in fetal development. Semin Cell Dev Biol. 2011;22(6):637–44. doi:10.1016/j.semcdb.2011.08.011.
  • Solomon L, Abrams G, Dinner M, et al. Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med. 1977;296(1):54–55. doi:10.1056/nejm197701062960123.
  • Harpey JP, Jaudon MC, Clavel JP, Galli A, Darbois Y. Cutis laxa and low serum zinc after antenatal exposure to penicillamine. Lancet. 1983;2(8354):858. doi:10.1016/S0140-6736(83)90783-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.